Aila Gareayaghi | Post-traumatic Stress Disorder | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Aila Gareayaghi | Post-traumatic Stress Disorder | Best Researcher Award

Dr. Aila Gareayaghi is a committed psychiatrist based in Kocaeli, Türkiye, with a deep passion for trauma-focused therapy, online psychotherapy, and mood and anxiety disorders. She holds the position of Lecturer and Psychiatrist at Kocaeli University and serves as Chair of the Kocaeli Branch of the Psychiatric Association of Türkiye. Dr. Gareayaghi’s extensive clinical and academic work includes innovative research on telepsychiatry, particularly in post-disaster mental health following Türkiye’s 2023 Kahramanmaraş Earthquakes. Her international experience includes a clerkship at Johns Hopkins University, Maryland. Beyond her clinical practice, she is active in research, conference presentations, and has authored multiple peer-reviewed publications addressing PTSD, sexual dysfunction, and transphobia in healthcare. Dr. Gareayaghi is multilingual, speaks advanced English and elementary French, and is a passionate advocate for volunteerism, animal welfare, and nature conservation, integrating her holistic outlook into her psychiatric practice.

Profile

🎓 Education

Dr. Aila Gareayaghi began her academic journey with a High School Diploma from Matthew McNair Secondary School in Vancouver, Canada (2012). She earned her Doctor of Medicine (M.D.) from Bezmialem Vakıf University, Istanbul, Türkiye (2012-2018), where she built a strong foundation in medical sciences. During her medical training, she completed a prestigious clerkship in Gastroenterology at Johns Hopkins University, USA (2018), gaining international exposure to advanced clinical practices. Pursuing her passion for mental health, she specialized in Psychiatry at Kocaeli University, Türkiye (2020-2024). Under the mentorship of Prof. Dr. Elif Tatlıdil, she completed her thesis on “Telepsychiatry Services During the February 6 Earthquakes and PTSD Prevalence Six Months Later.” Additionally, Dr. Gareayaghi continuously expanded her expertise through numerous certifications in psychotherapy, cognitive behavioral therapy, dynamic psychotherapy, EMDR, and traditional Chinese medicine, emphasizing her dedication to comprehensive psychiatric care.

🧪 Experience

Dr. Gareayaghi’s professional experience reflects a blend of clinical practice, teaching, and research. She currently serves as Lecturer and Psychiatrist at the Department of Psychiatry, Kocaeli University (2024–Present), where she actively treats patients, mentors students, and conducts impactful research. As Chair of the Kocaeli Branch of the Psychiatric Association of Türkiye, she plays a leadership role in advancing psychiatric practice and policy at the regional level. Her experience extends internationally, having completed a clinical clerkship in Gastroenterology at Johns Hopkins University, USA. Dr. Gareayaghi has presented her research extensively at national and international psychiatric congresses, covering topics from disaster psychiatry to psychosis and caregiver support. Her work demonstrates strong expertise in trauma therapy, online psychotherapy, and managing complex psychiatric conditions. She is also a prolific contributor to academic literature, authoring multiple peer-reviewed articles and book chapters addressing psychiatric emergencies and psychological trauma interventions.

🏅 Awards and Honors

Dr. Aila Gareayaghi has distinguished herself through numerous scientific contributions and recognitions. She has been invited as a speaker at prestigious forums such as the 59th National Psychiatry Congress and the Symposium on Disaster and Disaster Management. Her presentations on post-earthquake PTSD, antipsychotic-induced complications, and caregiver support have been recognized for their clinical relevance and academic rigor. Dr. Gareayaghi’s research, including peer-reviewed publications on telepsychiatry and transphobia in healthcare, reflects her innovative approach to contemporary psychiatric challenges. Although formal awards are not specified, her active involvement as Chair of the Kocaeli Branch of the Psychiatric Association of Türkiye and her multiple invited speaker roles demonstrate high professional regard and peer recognition. Moreover, her extensive certifications in psychotherapy modalities underscore her commitment to lifelong learning and excellence in patient care. Her dedication to volunteer work and animal welfare also highlight her compassionate engagement beyond academia.

🔬 Research Focus

Dr. Gareayaghi’s research focuses primarily on trauma-informed care, disaster psychiatry, and telepsychiatry, with a special emphasis on the mental health impact of natural disasters. Her thesis work examined the prevalence of PTSD following Türkiye’s 2023 earthquakes and the effectiveness of telepsychiatry services during disaster recovery. Additionally, her research explores societal and clinical aspects of sexual dysfunction, major depressive disorder, bipolar disorder, schizophrenia, and anxiety disorders. She has published studies addressing transphobia in healthcare, antipsychotic-induced complications, and innovative therapeutic interventions such as EMDR. Dr. Gareayaghi integrates various therapeutic modalities, including dynamic psychotherapy, cognitive behavioral therapy, and psychodynamic psychotherapy, into both her clinical practice and research. Her multidisciplinary approach bridges clinical psychiatry, public health, and social psychology, contributing valuable insights into the management of psychiatric emergencies and the psychological aftermath of crises. Her ongoing work continues to address evolving mental health challenges in both individual and systemic contexts.

✅ Conclusion

Dr. Aila Gareayaghi exemplifies a dynamic psychiatrist integrating clinical excellence, cutting-edge research, and compassionate care, with a focus on trauma therapy, disaster psychiatry, telepsychiatry, and comprehensive psychiatric education.

Publications

  • Ruh Sağlığında Kriz

    ÖGDA GAREAYAGHİ, UDH YILMAZ, A POLAT
    PSİKİYATRİK ACİLLER
  • A MEDICAL STUDENT’S PERSPECTIVE ON ANIMAL EXPERIMENTATION.
    A Gareayaghi
    The Turkish Journal of Gastroenterology: the Official Journal of Turkish …

  • Predictors of Transphobia and Attitudes Toward Transgender Individuals Among Nurses in Türkiye: A Cross-Sectional Study

    Healthcare
    2025-06-19 | Journal article
    DOI: 10.3390/healthcare13121474
    CONTRIBUTORS: Ezgi Şişman; Mehtap Güngör; Aila Gareayaghi; Hanife Yılmaz; Aslıhan Polat

  • Post-Earthquake PTSD and the Role of Telepsychiatry: A Six-Month Follow-Up Study After the 2023 Kahramanmaraş Earthquakes

    Medicina
    2025-06-17 | Journal article
    DOI: 10.3390/medicina61061097
    CONTRIBUTORS: Aila Gareayaghi; Elif Tatlıdil; Ezgi Şişman; Aslıhan Polat

  • Experiences with Brexpiprazole in the Management of Agitation Due to Dementia in a University Clinic: A Case Series

    Kocaeli Üniversitesi Sağlık Bilimleri Dergisi
    2025-03-21 | Journal article
    DOI: 10.30934/kusbed.1617807
    CONTRIBUTORS: Aila Gareayaghi; Ezgi Şişman; Mert Türksoy; Aslıhan Özlem Polat Işık

Dyandevi mathure | Nanoformulation for Alzheimer’s disease | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Dyandevi mathure | Nanoformulation for Alzheimer’s disease | Best Researcher Award

Dr. Dyandevi Mewalal Mathure, Assistant Professor at Bharati Vidyapeeth, Poona College of Pharmacy, Pune, is a distinguished academician with over 15 years of experience in pharmaceutical sciences. Holding a Ph.D. in Pharmaceutical Sciences, she has significantly contributed to teaching, research, and innovation. Dr. Mathure has authored three notable books, published 18 research articles in reputed journals, and holds five published patents. Her research primarily focuses on nanoformulations for Alzheimer’s disease, wound healing, and topical formulations for skin diseases. She has successfully completed government-funded research projects and is actively engaged in industry consultancy work. Collaborating with institutions like the University of Petroleum and Energy Studies, Dehradun, Dr. Mathure continues to push the frontiers of pharmaceutical research. Her dedication is reflected in multiple accolades, including best paper presentation awards at international conferences. Committed to translational pharmaceutical advancements, she remains a passionate contributor to academia and industry alike.

Profile

🎓 Education

Dr. Dyandevi Mewalal Mathure earned her Ph.D. in Pharmaceutical Sciences, building a robust foundation in pharmaceutical research and innovation. Her academic journey has been characterized by a strong emphasis on novel drug delivery systems, formulation development, and translational research. She has engaged in continuous professional development, authoring several key texts in Industrial Pharmacy and Modern Dispensing Practices, which are widely used in academic curricula. Her educational background not only reflects depth in pharmaceutical sciences but also showcases her commitment to knowledge dissemination through teaching and publication. Her advanced training and research expertise in nanoformulations, brain-targeted drug delivery, and topical therapeutic systems underscore her position as a subject matter expert. Dr. Mathure’s education has enabled her to bridge theory and practice, equipping her with the skills to lead significant research projects, collaborate with industry partners, and mentor future pharmacists and researchers.

🧪 Experience

With over 15 years of academic and research experience, Dr. Dyandevi Mewalal Mathure has built a distinguished career as an Assistant Professor at Bharati Vidyapeeth, Poona College of Pharmacy, Pune. Her professional journey encompasses extensive teaching, research supervision, and collaborative research projects. She has published 18 papers in esteemed SCI and Scopus-indexed journals, authored three textbooks, and successfully filed five patents. Dr. Mathure has completed one funded research project and is currently engaged in an ongoing industry consultancy project, demonstrating her ability to translate academic research into practical applications. Her collaborations with institutions like the University of Petroleum and Energy Studies highlight her commitment to multidisciplinary research. Additionally, her expertise in nanoformulations for Alzheimer’s disease, wound healing, and skin disorders reflects her diverse research interests. Through her dedicated mentorship and active participation in international conferences, she continues to inspire and guide students, contributing significantly to the advancement of pharmaceutical sciences.

🏅 Awards and Honors

Dr. Dyandevi Mewalal Mathure has been recognized for her outstanding research contributions through multiple awards and honors. Notably, she received the Best Paper Presentation Award at the international e-Conference on “Expanding Frontier of Pharmaceutical Research Towards Global Exigency,” organized by Karpagam College of Pharmacy in association with the Indian Pharmaceutical Association, Coimbatore Branch. Her consistent scholarly excellence is reflected in her extensive publication record and successful patent filings. Dr. Mathure’s innovative work has garnered appreciation from both academia and industry, enhancing her reputation as a leader in pharmaceutical research. In addition to her academic accolades, her active involvement in consultancy projects further validates the real-world impact of her research. Her sustained commitment to innovation, teaching excellence, and translational research has made her a strong contender for the Best Research Award, recognizing her as a role model in the field of pharmaceutical sciences.

🔬 Research Focus

Dr. Dyandevi Mewalal Mathure’s research focuses on developing advanced nanoformulations aimed at treating Alzheimer’s disease, promoting wound healing, and addressing various dermatological conditions through innovative topical formulations. Her work emphasizes the design and optimization of novel drug delivery systems that enhance therapeutic efficacy and patient compliance. Through her publications, patents, and consultancy projects, Dr. Mathure has contributed to the advancement of brain-targeted drug delivery, an area critical for managing neurodegenerative diseases. Her translational research bridges laboratory discoveries with clinical and industrial applications, offering practical solutions to complex medical challenges. Collaborations with reputed institutions like UPES Dehradun further demonstrate her commitment to multidisciplinary and applied pharmaceutical research. With a citation index of 6, she maintains an active presence in scientific discourse, continuously advancing the boundaries of pharmaceutical sciences. Her work exemplifies innovation-driven research with tangible societal impact.

✅ Conclusion

Dr. Dyandevi Mewalal Mathure’s distinguished academic career, marked by impactful research in nanoformulations, drug delivery, numerous publications, patents, and active industry collaborations, demonstrates her unwavering commitment to advancing pharmaceutical sciences and improving patient care through innovation and translational research.

Publications

Andreea-Teodora IACOB | Biomedical Applications of polymeric materials | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Andreea-Teodora IACOB | Biomedical Applications of polymeric materials | Best Researcher Award

Dr. Andreea-Teodora Iacob is a dedicated Lecturer PhD and Specialist Pharmacist at the Department of Pharmaceutical Chemistry, Faculty of Pharmacy, “Grigore T. Popa” University of Medicine and Pharmacy Iași, Romania. She has established a remarkable profile in the fields of pharmaceutical chemistry, drug design, and advanced polymeric systems for biomedical applications. With an impressive academic and professional trajectory, Dr. Iacob has contributed extensively to multidisciplinary research on heterocyclic compounds, nanostructured drug delivery systems, and wound healing materials. She holds multiple specialist certifications in pharmaceutical laboratory, clinical pharmacy, and the pharmaceutical-cosmetic industry. She has co-authored over 47 ISI-indexed publications, edited scientific volumes, and has been awarded several national and international accolades for her scientific contributions. Passionate about research, teaching, and collaboration, Dr. Iacob actively mentors students and serves as an editor and reviewer for reputed journals, while also engaging in national and international collaborative projects across pharmaceutical sciences.

Profile

🎓 Education

Dr. Iacob’s academic formation is grounded in pharmaceutical sciences, with a progressive specialization in both academic and clinical domains. She completed her Doctorate in Pharmaceutical Chemistry with research focusing on innovative biomaterials for wound management. In 2018, she earned certification as a Specialist Pharmacist in Pharmaceutical Laboratory from “Saint Spiridon” Clinical Hospital, Iași. In 2021, she added a second specialty in Clinical Pharmacy, and in 2025, she will complete her third specialty in Pharmaceutical and Cosmetic Industry. She enriched her academic background with a postdoctoral research fellowship (2019–2021) at the Faculty of Applied Chemistry and Materials Science in Bucharest, developing novel chitosan/PEO-based films for wound healing. Her academic journey is further enhanced by intensive involvement in national doctoral and postdoctoral training projects. Her education is marked by a continuous commitment to learning, research innovation, and application of chemistry and pharmacology for therapeutic benefit, laying the foundation for her dynamic research and teaching career.

🧪 Experience

Dr. Andreea-Teodora Iacob has over a decade of rich academic and clinical experience. Since February 2020, she serves as a Lecturer PhD in Pharmaceutical and Therapeutic Chemistry at UMF Iași, where she contributes to both undergraduate and postgraduate education. She began her clinical specialization as a pharmacist in 2018 and evolved through additional specializations in clinical pharmacy and pharmaceutical industries. From August 2019 to January 2021, she pursued postdoctoral research in chemical engineering, focusing on polymeric wound dressings. Her expertise spans drug synthesis, physicochemical characterization, nanotechnology, and biomedical formulations. Dr. Iacob has also participated in several European-funded training programs aimed at developing applied research and entrepreneurship skills. Her work encompasses laboratory management, student supervision, and interdisciplinary research. Additionally, she contributes to curriculum development and academic publishing, while maintaining active collaborations with national and international institutions. Her balanced experience in teaching, clinical practice, and research distinguishes her as a versatile pharmaceutical professional.

🏅 Awards and Honors

Dr. Iacob has received wide recognition for her innovative research. She won the Bronze and Silver Medals at EuroINVENT 2025 in Iași, acknowledging her contributions to wound healing and pharmaceutical formulations. She was among the five winners of the L’Oréal-UNESCO For Women in Science Young Talents Romania Program 2023, a prestigious award that supports early-career female researchers. Her papers have earned Best Paper Awards at multiple International Scientific Conferences, including “Applications of Chemistry in Nanosciences and Biomaterials Engineering.” With an H-index of 13 (WOS) and 16 (Google Scholar), her work has been cited over 1000 times, highlighting her influence in the scientific community. She also serves as a Guest Editor for Polymers and Pharmaceutics, and as a substitute member of the COST EU Action CA19140, promoting advanced ion technologies. These honors showcase her dedication to impactful research, leadership in academia, and commitment to promoting women in science.

🔬 Research Focus

Dr. Iacob’s research bridges pharmaceutical chemistry, nanotechnology, and regenerative medicine. Her expertise centers on the synthesis of heterocyclic compounds (azetidin-2-ones, thiazolidine-4-ones, azomethines, hydrazones) with therapeutic potential, including antimicrobial, antioxidant, anti-inflammatory, and cytotoxic activities. She is also deeply involved in the design and evaluation of polymeric biomaterials such as hydrogels, sponges, and films, especially chitosan-based systems, for skin and wound therapy. She has pioneered work on electrospun nanofibers and niosomes, exploring their structural, functional, and biological characteristics for use in chronic wound healing. Her work integrates advanced synthesis methods, spectral analysis (IR, NMR, HRMS), and in vitro biological evaluation. She contributes to eight national and two international research projects and collaborates with leading institutions across Europe. Her multidisciplinary research reflects a commitment to translational science, bridging fundamental chemistry with practical medical applications, especially in skin regeneration, controlled drug delivery, and therapeutic polymer design.

✅ Conclusion

Dr. Andreea-Teodora Iacob is an accomplished pharmaceutical chemist and educator whose impactful contributions in heterocyclic drug design, nanostructured wound therapies, and polymeric biomaterials—supported by high-impact publications, patents, national and international projects, and prestigious awards—make her a leading figure in pharmaceutical research and an outstanding nominee for the Best Researcher/Women Research Award.

Publications

Milana Frenkel-Morgenstern | Liquid Biopsy | Women Researcher Award

Published on by Cognitive Scientist Awards

Dr. Milana Frenkel-Morgenstern | Liquid Biopsy | Women Researcher Award

Dr. Milana Frenkel-Morgenstern is an Israeli scientist and Principal Investigator at the Scojen Institute of Synthetic Biology, Reichman University. She specializes in bioinformatics, systems biology, and synthetic biology. With a rich background spanning molecular genetics, computer science, and structural biology, she has held key positions in institutions such as Bar-Ilan University, Weizmann Institute of Science, and the Spanish National Research Centre. She is renowned for her pioneering work in liquid biopsies, chimeric RNAs, and non-invasive diagnostic tools. Dr. Frenkel-Morgenstern has published extensively, served on prestigious evaluation panels, and received numerous fellowships and awards, including the Miguel Servet Fellowship and the Rector Prize for Scientific Innovation. Her leadership in both academic and public scientific communities, combined with a strong record of mentorship and university service, highlights her influential presence in biomedical research. She is also the founder of the “Art in Science” session at ISMB, reflecting her commitment to interdisciplinary innovation.

Profile

🎓 Education

Dr. Frenkel-Morgenstern earned her PhD in Molecular Genetics at the Weizmann Institute of Science under Prof. Shmuel Pietrokovski, specializing in bioinformatics and systems biology. Prior to that, she completed her MSc in Mathematics and Computer Science with a thesis in molecular biology from Bar-Ilan University, mentored by Prof. Ron Unger and Prof. Amihood Amir. Her undergraduate studies were also at Bar-Ilan University, where she earned a BSc in Mathematics and Computer Science. Her multidisciplinary education seamlessly blends life sciences, computational modeling, and mathematical analysis, forming the foundation for her later innovations in biomedical research. This strong computational background, coupled with a deep understanding of molecular biology, positioned her to excel in complex systems analysis, machine learning, and genomics, leading to a distinguished academic and research career. Her training has enabled her to lead translational biomedical projects, particularly in the fields of cancer research, structural bioinformatics, and synthetic biology.

🧪 Experience

Dr. Milana Frenkel-Morgenstern has over two decades of academic and research experience. She is currently Principal Investigator and Senior Lecturer at Reichman University. Prior to this, she was a senior faculty member at Bar-Ilan University’s Azrieli Faculty of Medicine for a decade. Internationally, she served as a staff scientist at the Spanish National Cancer Research Centre (CNIO) and was a postdoctoral fellow in the labs of Prof. Alfonso Valencia and Prof. Uri Alon. She has also been a scientific advisor and educator at the Weizmann Institute’s Davidson Institute. Dr. Frenkel-Morgenstern has taught a range of graduate-level courses in genomics, bioinformatics, and computational biology. She has been deeply involved in institutional governance, serving on data science boards, senate committees, and multiple departmental leadership roles. Her professional journey reflects a blend of research excellence, teaching dedication, and scientific outreach, including organizing the “Art in Science” initiative for ISMB/ECCB.

🏅 Awards and Honors

Dr. Frenkel-Morgenstern has received numerous prestigious awards recognizing her research and innovation. She was awarded the Rector Prize for Scientific Innovation by Bar-Ilan University in 2021, and the Bioinfo4Women Fellowship by the Barcelona Supercomputing Center from 2016–2019. Her work on RNA sequencing earned her the Miguel Servet Fellowship (2011–2015), and she received international postdoctoral fellowships from Caja Navarra Foundation and Horvitz Foundation. Her academic contributions have been recognized through several Travel Awards from ISMB, ECCB, and RECOMB, and she earned Outstanding Poster Awards in international conferences. As a guest editor for leading journals and evaluator for major funding bodies (ERC, ISF, GIF, etc.), her influence extends beyond research to shaping the global scientific agenda. She also received the Excellent Lecturer Award (2017) at Bar-Ilan University and serves as an academic reviewer and thesis evaluator for institutions across Israel, Europe, and Asia, demonstrating global academic leadership.

🔬 Research Focus

Dr. Frenkel-Morgenstern’s research centers on liquid biopsy technologies, cell-free nucleic acids (cfDNA/cfRNA), and systems and synthetic biology. Her lab investigates molecular biomarkers for cancer, arthritis, and prenatal diagnostics, developing computational platforms that utilize next-generation sequencing, AI, and machine learning. She explores chimeric RNAs, chromosomal translocations, and non-optimal codon usage, linking genetic regulation with disease mechanisms. Her interdisciplinary work bridges microbiome analysis, metagenomics, genome profiling, and protein-protein interaction networks, with translational applications in personalized medicine. In addition, she applies big data analytics to understand the cell cycle, identify druggable targets, and improve early diagnostics using non-invasive methods. Dr. Frenkel-Morgenstern is also investigating novel areas such as the relationship between melanin, Vitamin D, and mRNA technologies, relevant to both clinical and cosmetic science. Her research is both hypothesis-driven and data-intensive, aiming to convert large-scale biological data into practical medical insights and biotechnology solutions with significant societal impact.

✅ Conclusion

Dr. Milana Frenkel-Morgenstern is a leading scientist in bioinformatics and synthetic biology whose interdisciplinary research in liquid biopsies, systems biology, and AI-driven genomics continues to impact cancer diagnostics and translational medicine globally.

Publications

  • Applications for Circulating Cell-Free DNA in Oral Squamous Cell Carcinoma: A Non-Invasive Approach for Detecting Structural Variants, Fusions, and Oncoviruses

    Cancers
    2025-06 | Journal article | Author
    DOI: 10.3390/cancers17121901
    CONTRIBUTORS: Mahua Bhattacharya; Dan Yaniv; Dylan P. D’Souza; Eyal Yosefof; sharon tzelnick; Rajesh Detroja; Tal Wax; Adva Levy-Barda; Gideon Baum; Aviram Mizrachi et al.

  • ChiTaRS 8.0: the comprehensive database of chimeric transcripts and RNA-seq data with applications in liquid biopsy

    Nucleic Acids Research
    2025-01-06 | Journal article
    DOI: 10.1093/nar/gkae1126
    CONTRIBUTORS: Dylan DSouza; Lihi Bik; Olawumi Giwa; Shahaf Cohen; Hilit Levy Barazany; Tali Siegal; Milana Frenkel-Morgenstern

  • The applications of circulating cell-free DNA for oral squamous cell carcinoma patients as non-invasive diagnostics of structural variants, fusions and oncoviruses

    2023-11-30 | Preprint
    DOI: 10.1101/2023.11.29.23299177
    CONTRIBUTORS: Mahua Bhattacharya; Dan Yaniv; Eyal Yosefof; Sharon Tzelnick; Rajesh Detroja; Dylan P. D’Souza; Gidi Baum; Aviram Mizrachi; Gideon Bachar; Milana Frenkel Morgenster

Agota Apati | Stem Cell Based Disease Modelling | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Agota Apati | Stem Cell Based Disease Modelling | Best Researcher Award

Dr. Ágota Apáti, PhD, DSc, is a distinguished Hungarian molecular biologist and Senior Research Associate at the Institute of Molecular Life Sciences, Research Centre for Natural Sciences. She leads the Pluripotent Stem Cell Laboratory and is renowned for establishing Hungary’s first human pluripotent stem cell lab. With over 70 publications and an H-index of 25, her work is widely recognized internationally. Dr. Apáti’s research encompasses human iPSC-derived disease models, membrane transporters, and cellular signaling pathways, with implications in schizophrenia, diabetes, and rare syndromes. She has supervised numerous PhD students and maintains active roles in both national and international scientific societies. Her commitment to translational stem cell research and ethical scientific practice positions her as a leading figure in the field of regenerative medicine and cellular therapeutics.

Profile

🎓 Education

Dr. Ágota Apáti holds a Master of Science (MSc) degree in Chemistry from Eötvös Loránd University of Sciences, Budapest (1984–1989). She later pursued doctoral studies and earned her PhD from Semmelweis Medical University (1998–2003), focusing on molecular and cellular aspects of hematology and immunology. Her academic training blends rigorous biochemical education with advanced medical sciences, establishing a solid foundation for her research career in stem cell biology and cellular therapeutics. Through continuous engagement in teaching and supervising graduate students, she has also remained an integral part of academic development at Hungary’s premier institutions. Her strong interdisciplinary background supports her work on complex cellular processes and disease modeling, and she is also a Doctor of Science (DSc, 2024) from the Hungarian Academy of Sciences—an honor awarded for substantial contributions to biomedical research in Hungary.

🧪 Experience

With over three decades of research experience, Dr. Ágota Apáti began her scientific career as a Research Fellow at Semmelweis Medical University (1989–1993). She progressed through multiple institutions, including the National Institute of Haematology and Immunology (1993–2004) and the National Blood Service (2005–2013), where she led various molecular biology projects. Between 2013 and 2023, she was a Senior Research Associate and lab head at the Institute of Enzymology, Hungarian Academy of Sciences. Since 2023, she continues her leadership as Laboratory Head at the Institute of Molecular Life Sciences under HUNREN. She has consistently taught and mentored postgraduate students in biochemistry, hematology, immunology, and membrane biology. Dr. Apáti’s collaborative and interdisciplinary projects have helped develop multiple disease models and cellular assays. Her scientific leadership has been instrumental in expanding Hungary’s role in cutting-edge stem cell research and molecular diagnostics.

🏅 Awards and Honors

Dr. Ágota Apáti has been recognized both nationally and internationally for her contributions to biomedical research. Early in her career, she received the prestigious UNIDO award during the ICRO course on RNA structure and function in Trieste, Italy (1994). In 2024, she was awarded the Doctor of Science (DSc) degree by the Hungarian Academy of Sciences—a distinguished title granted to researchers with a substantial, impactful body of scientific work. Her membership in renowned scientific organizations, such as the International Society for Stem Cell Research (ISSCR), Hungarian Society of Biology, Hungarian Society of Biochemistry, and the Hungarian Medical Research Council’s Ethical Board for Human Reproduction, underscores her stature in the field. These accolades not only reflect her scientific excellence but also her contributions to ethical research practice, public health, and mentoring within the scientific community, cementing her reputation as a key contributor to molecular life sciences.

🔬 Research Focus

Dr. Apáti’s research centers on pluripotent stem cells, disease modeling, and cellular signaling. She specializes in generating and differentiating human induced pluripotent stem cells (iPSCs) into neuronal, cardiac, mesenchymal, and endothelial lineages. Her work extends into disease modeling for schizophrenia, arteriosclerosis, diabetes, DiGeorge syndrome, and Frank-Ter Haar syndrome using patient-derived iPSC lines and CRISPR-based genome editing. She has developed cellular reporter systems to study membrane transporter function and calcium signaling pathways, significantly advancing understanding in neuropsychiatric and cardiovascular disorders. Through integrative omics and 3D organoid models, Dr. Apáti’s lab explores metabolic and genetic dysregulation in human pathologies. Her translational research aims to identify drug targets and therapeutic strategies using patient-specific cell lines. She also investigates multidrug resistance in stem cells and cancer, contributing to better clinical interventions. Her multidisciplinary projects bridge fundamental biology with clinical relevance, making her a vital contributor to regenerative medicine and personalized therapy.

✅ Conclusion

Dr. Ágota Apáti is a trailblazing scientist whose pioneering work in human stem cell research, disease modeling, and membrane biology continues to shape translational medicine, with a sustained commitment to research excellence, scientific mentorship, and ethical innovation in biomedical sciences.

Publications

  • Haloperidol, Olanzapine, and Risperidone Induce Morphological Changes in an In Vitro Model of Human Hippocampal Neurogenesis

    Biomolecules
    2024-06 | Journal article | Author
    DOI: 10.3390/biom14060688
    CONTRIBUTORS: Bálint Jezsó; Sára Kálmán; Kiara Gitta Farkas; Edit Hathy; Katalin Vincze; Dzsenifer Kovács-Schoblocher; Julianna Lilienberg; Csongor Tordai; Zsofia Nemoda; László Homolya et al.

  • Partial Disturbance of Microprocessor Function in Human Stem Cells Carrying a Heterozygous Mutation in the DGCR8 Gene

    Genes
    2022-10 | Journal article | Author
    DOI: 10.3390/genes13111925
    CONTRIBUTORS: Dóra Reé; Ábel Fóthi; Nóra Varga; Orsolya Kolacsek; Tamas Orban; Agota Apat

  • A Novel Cell-Based Model for a Rare Disease: The Tks4-KO Human Embryonic Stem Cell Line as a Frank-Ter Haar Syndrome Model System

    International Journal of Molecular Sciences
    2022-08 | Journal article | Author
    DOI: 10.3390/ijms23158803
    CONTRIBUTORS: Loretta László; Hédi Maczelka; Tamás Takács; Anita Kurilla; Álmos Tilajka; László Buday; Vas Virag; Agota Apati
  • Synthesis and Systematic Investigation of Lepidiline A and Its Gold(I), Silver(I), and Copper(I) Complexes Using In Vitro Cancer Models and Multipotent Stem Cells

 

Huifang Wang | Neuroscience | Best Researcher Award

Published on by Cognitive Scientist Awards

 Dr. Huifang Wang | Neuroscience | Best Researcher Award

Huifang Elizabeth Wang is a leading research engineer at INSERM U1106, Aix-Marseille University, France, specializing in computational neuroscience. Her career bridges robotics, brain modeling, and clinical neuroscience, with a primary focus on personalized brain simulations for neurological and psychiatric conditions, notably epilepsy. With over a decade of postdoctoral research across top French and Italian institutes, she has contributed to projects integrating physics-based modeling, large-scale neural dynamics, and effective connectivity. Her academic journey started in robotics and control theory in China and evolved into advanced brain modeling in Europe. She collaborates with renowned neuroscientists like Dr. Viktor Jirsa and has authored numerous high-impact publications in Science Translational Medicine, The Lancet Neurology, and NeuroImage. As PI and co-leader in several EU and national projects, she aims to bridge basic brain science with clinical translation. Wang’s work is pivotal in creating virtual brain twins to personalize epilepsy surgery and psychiatric interventions.

Profile

🎓 Education

Huifang Elizabeth Wang obtained her Ph.D. in Pattern Recognition and Intelligent Systems from Beijing University of Technology in 2008, focusing on optimization algorithms for robotic motion under Prof. Chen Yangzhou. She earned her M.S. from the same institution in 2003, researching advanced traffic control strategies. Her undergraduate degree (B.S.) in Electronic Engineering was awarded by Shandong Institute of Light Industry in 2000. Complementing her engineering foundation, she undertook a research visit at LAAS-CNRS in Toulouse in 2007, developing time-optimal trajectories for car-like robots. Currently, she is finalizing her HDR (Habilitation à Diriger des Recherches) at Aix-Marseille University (Nov 2024) under the supervision of Dr. Viktor Jirsa, with a thesis on “Virtual Brain Twins.” Her education spans multiple disciplines and institutions, combining engineering, neuroscience, and clinical modeling. This interdisciplinary background underpins her leadership in personalized neural modeling and translational neuroscience research.

🧪 Experience

Wang is a Research Engineer at INSERM U1106, Aix-Marseille University (2017–present), leading work on virtual brain twins for clinical use in epilepsy and psychiatry. Prior, she was a Postdoc at the Institut du Cerveau (ICM), Paris (2016–2017), studying human neuron behavior with Pr. Vincent Navarro. At École des Mines de Saint-Étienne (2016), she helped develop a physiological SEEG atlas. From 2012–2016, she worked at INSERM U1106 on brain connectivity under Drs. Bernard and Jirsa. Earlier, she researched robotic control and planning at the University of Pisa (2008–2010) in Prof. Antonio Bicchi’s group. Her expertise spans brain modeling, robotics, and neuroscience, with leadership in multi-institutional EU-funded projects. She has served as PI and co-leader in several major efforts like the Human Brain Project and EPINOV. Her interdisciplinary experience uniquely equips her to bridge theory, technology, and medicine in brain modeling applications.

🏅 Awards and Honors

Huifang Elizabeth Wang has earned prestigious research roles and leadership positions in major European and national initiatives. She is PI for the AMIDEX-funded HR-VEP project and WP4 leader in the Horizon RIA Virtual Brain Twin initiative (2024–2027). Her projects have been supported by the Human Brain Project, France 2030, and Horizon Europe. She served as co-task leader in HBP’s epilepsy-focused work packages and trial coordinator in EPINOV RHU, a national clinical modeling trial. Her work on brain modeling has been published in high-impact journals, underscoring her scientific excellence. She has collaborated with pioneers like Karl Friston and Viktor Jirsa, advancing the fields of functional connectivity and computational neuroscience. Additionally, she has been granted funding by institutions such as Fondation Recherche Médicale and Ligue Française contre l’Épilepsie, recognizing her contributions to translational neuroscience and computational modeling in clinical applications.

🔬 Research Focus

Wang’s research centers on developing personalized virtual brain models to understand and treat brain disorders such as epilepsy and psychiatric conditions. She specializes in large-scale neural modeling using neural mass and field models, enabling individual-specific simulations—a concept known as “virtual brain twins.” Her work integrates multimodal neuroimaging data (e.g., SEEG, MRI) with computational frameworks to predict surgical outcomes and guide interventions. As part of projects like VEP Atlas, EPINOV, and EBRAINS, she builds anatomical-functional atlases for clinical use. She also advances Bayesian techniques for parameter estimation in brain modeling. Her research bridges basic neuroscience with translational applications, using virtual brains to delineate epileptogenic zones and simulate drug-resistant epilepsy spread. In psychiatric disorders, her focus includes simulating and analyzing network dysfunction to support precision psychiatry. By blending machine learning, dynamical systems, and neuroinformatics, Wang’s work pioneers a new frontier in personalized medicine using brain simulations.

✅ Conclusion

Dr. Huifang Elizabeth Wang is an interdisciplinary researcher transforming clinical neuroscience through virtual brain modeling, combining engineering precision with neuroscientific insight. Her pioneering work in virtual brain twins supports individualized diagnosis and treatment of epilepsy and psychiatric disorders, representing a significant advance in precision medicine. With extensive experience, numerous publications, and leadership in high-impact research projects, she bridges theory and practice. Her scientific vision and collaborative leadership continue to shape the future of computational neuroscience and neurotechnology for patient care worldwide.

Publications

Ishrat Mahjabeen | Tumor Biomarkers | Best Scholar Award

Published on by Cognitive Scientist Awards

Dr. Ishrat Mahjabeen | Tumor Biomarkers | Best Scholar Award

Academician/Research Scholar |COMSATS University Islamabad, Pakistan

Dr. Ishrat Mahjabeen is an accomplished molecular biologist and cancer geneticist currently serving as Associate Professor at COMSATS University Islamabad, with extensive expertise in head and neck cancer, gene regulation, and microRNA biology. She earned her PhD in Cancer Genetics from COMSATS and recently completed a prestigious Fulbright Postdoctoral Fellowship at Brown University, USA. Dr. Mahjabeen has over two decades of research and academic experience, contributing significantly to molecular oncology through her work on base excision repair pathway genes, miRNA dysregulation, and genetic polymorphisms. She has also been an active educator, having supervised numerous undergraduate and graduate students and taught a variety of bioscience courses. Her scholarly contributions include a Springer book chapter and multiple international conference presentations. With a deep commitment to cancer research and academic mentorship, she continues to shape the future of biomedical science in Pakistan and beyond through her innovative work and international collaborations.

Profile

🎓 Education

Dr. Ishrat Mahjabeen holds a diverse academic background rooted in biological sciences. She earned her Postdoctoral Research Fellowship (2023–2024) from Brown University, USA, through the esteemed Fulbright Scholarship Program. Her PhD in Cancer Genetics was awarded by COMSATS Institute of Information Technology Islamabad in 2013, where she conducted a thesis on deregulated base excision repair pathway genes and microRNAs in head and neck cancer. Prior to her doctorate, she completed her M.Phil. in Developmental Biology from Quaid-e-Azam University in 2006, focusing on methylcobalamin’s role in sciatic nerve regeneration in rabbits. Her academic journey began with an MSc in Zoology from the University of Arid Agriculture Rawalpindi in 2003, where she explored the impact of temperature on arthropod populations. This strong foundation across developmental biology, zoology, and cancer genetics has equipped her with a multi-dimensional understanding of complex biological systems, enabling her significant contributions to cancer research and biosciences education.

🧪 Experience

Dr. Ishrat Mahjabeen has over 20 years of rich research and academic experience in biosciences and molecular oncology. Since May 2024, she has been serving as Associate Professor at COMSATS University Islamabad, where she previously held the positions of Assistant Professor (2017–2024) and Senior Scientific Officer (2014–2017). Her academic journey began with research fellowships at leading institutions, including the Center for Molecular Biology of Oral Diseases at the University of Illinois at Chicago, Quaid-e-Azam University, and PMAS Arid Agriculture University. She also contributed as an honorary lecturer in Talagang. As a committed educator, she has supervised over 140 students across BS, MS, and PhD levels and has taught advanced courses in molecular biology, research techniques, and biochemistry. Her leadership in academia is marked by dedication to translational cancer research, curriculum development, and capacity building in the life sciences, fostering innovation and scientific rigor among emerging researchers.

🏅 Awards and Honors

Dr. Ishrat Mahjabeen has been honored with the prestigious Fulbright Postdoctoral Research Fellowship (2023–2024) at Brown University, USA—an international recognition of her excellence in cancer genetics research. Her academic achievements and research impact have earned her continued faculty promotions within COMSATS University Islamabad, reflecting her contributions to teaching, student mentorship, and scientific leadership. She has received recognition for her work through invited talks and presentations at notable global scientific platforms, including the American Association of Extracellular Vesicles (AAEV 2023) in Boston and multiple international conferences in Turkey and Pakistan. Her chapter contribution in a Springer book on head and neck cancer highlights her thought leadership in molecular oncology. These accolades underscore her pioneering work in cancer biology, particularly in miRNA and gene regulation research, as well as her role in fostering academic excellence and collaborative innovation across borders.

🔬 Research Focus

Dr. Ishrat Mahjabeen’s research centers on molecular oncology with a focus on genetic and epigenetic mechanisms underlying cancer development, particularly head and neck cancers. Her PhD work explored deregulated base excision repair pathway genes and the role of microRNAs in tumor progression. She investigates how miRNA dysregulation, gene polymorphisms, and checkpoint kinase alterations contribute to tumorigenesis, with significant emphasis on gliomas, gastric cancer, and H. pylori-associated pathogenesis. Dr. Mahjabeen is also involved in studying exosomal miRNAs and their functional targets, aiming to identify biomarkers and therapeutic targets. Her translational research approach integrates molecular biology with bioinformatics to unravel cancer pathways and personalize treatment strategies. Her postdoctoral research at Brown University further broadened her scope, allowing global collaborations and access to advanced genomic tools. She remains committed to bridging basic research and clinical relevance to improve early cancer diagnostics and targeted therapies in low-resource healthcare settings.

✅ Conclusion

Dr. Ishrat Mahjabeen stands out as a dynamic academic and cancer researcher, combining excellence in teaching, mentorship, and cutting-edge molecular oncology. Her global exposure, leadership in translational research, and unwavering commitment to biosciences make her an asset to the scientific community.

4o
Publications

Joan Lluis Vives Corrons | Anemias Raras | Breakthrough Research Award

Published on by Cognitive Scientist Awards

Prof. Joan Lluis Vives Corrons | Anemias Raras | Breakthrough Research Award

Prof. Joan-Lluis Vives-Corrons is a globally recognized expert in haematology with over five decades of experience in red cell pathology and rare anaemias. He has served as Head of the Haematology Laboratory and the Red Cell Pathology Unit at Hospital Clinic, University of Barcelona. As a pioneer in haematology standardization, he was instrumental in implementing quality control measures and advancing diagnostic techniques. A prolific researcher and educator, Prof. Vives-Corrons has authored over 500 scientific publications and coordinated major national and European projects focused on haemoglobinopathies and red blood cell enzymopathies. He founded and led the European Network for Rare and Congenital Anaemias (ENERCA), contributing significantly to policy, epidemiology, and clinical care for rare diseases. His visionary leadership has also been key in establishing newborn screening programs in Catalonia. Today, he continues his academic and research involvement as Emeritus Professor at the University of Barcelona and leader of collaborative European initiatives.

Profile

Education 🎓

Prof. Vives-Corrons completed his Medicine degree with honors from the University of Barcelona in 1969 and earned his MD in 1975, followed by specialization in Haematology in 1982. His early training included fellowships at prestigious institutions, including Hôpital Beaujon in Paris (1972) and The Scripps Research Institute, USA (1988). His academic tenure began in 1973 as a medical assistant at the University of Barcelona’s School of Haematology, and he was appointed Professor of Medicine in 1984. His education laid the foundation for a career focused on haematological diagnostics, molecular mechanisms of red blood cell disorders, and clinical laboratory standardization. With a strong international orientation, he integrated research, clinical care, and teaching, gaining expertise in both theoretical and practical haematology. His diverse educational background and training experiences have enabled him to foster innovation in both clinical and academic settings, influencing generations of haematologists across Spain and Europe.

Experience 👨‍🏫

Prof. Vives-Corrons held key positions over a distinguished 50-year career. From 1976 to 1996, he was Head of the Haematology Laboratory at Hospital Clinic, University of Barcelona, advancing diagnostic procedures and quality assessment in haematology. He later led the Red Cell Pathology Unit (1997–2016), recognized nationally as a reference center for rare anaemias. From 2017 to 2023, he led the Red Cell Pathology and Haematopoietic Disorders Group at the Josep Carreras Institute. He currently heads the Haematology Department at the Clinical Centre for Ambulatory Medicine. He has coordinated over 35 research projects, 90% as Principal Investigator, focusing on hereditary anaemias, molecular diagnostics, and epidemiology. His leadership in creating external quality assessment programs and coordinating the Catalan newborn screening program for Sickle Cell Disease marks his impactful public health contributions. Additionally, he has extensively contributed to academic training and was instrumental in establishing ENERCA for rare anaemia networking across Europe.

Awards & Recognitions 🏅

Prof. Vives-Corrons is the recipient of numerous national and international honors. He served as Secretary General of the International Society of Hematology (1988–1998) and was appointed member of the EU Committee of Experts on Rare Diseases (EUCERD). He contributed to the development of ISO/EN 15189, a global standard for clinical laboratory quality. As principal investigator, he led European Commission-funded ENERCA projects and co-developed Catalonia’s sickle cell screening program. His leadership in launching the Catalan Network for major haemoglobinopathies earned recognition for improving patient care and public health policy. He is an active member of top scientific societies including ASH, ISH, ISLH, and the Spanish Society of Hematology. His editorial roles span key journals like Haematologica and Orphanet Journal of Rare Diseases. With over 500 peer-reviewed publications and pioneering work in rare anaemias, his contributions have been instrumental in transforming haematology research, diagnosis, and clinical protocols across Europe.

Research Interests 🔬

Prof. Vives-Corrons’s research centers on red blood cell pathology, particularly congenital and acquired haemolytic anaemias. He has extensively investigated the physiopathology, genetic basis, and molecular mechanisms of rare anaemias, including G6PD and pyruvate kinase deficiencies, haemoglobinopathies like thalassaemia and sickle cell disease, and membrane disorders such as hereditary spherocytosis. His work has led to the discovery of novel genetic mutations in alpha globin and enzyme-deficiency genes. He also pioneered automation and standardization in haematology laboratories and was instrumental in creating Spain’s first EQAS system. His broader focus includes developing European collaborative networks (e.g., ENERCA) to improve diagnosis, treatment access, and epidemiological tracking of rare anaemias. He is a strong advocate of translational research, integrating laboratory discoveries into clinical applications. His efforts have helped establish molecular diagnostics and newborn screening as public health priorities in rare disease management, contributing significantly to patient care, education, and healthcare policy across Europe.

Publications
  • Angastiniotis M, Vives Corrons JL, Soteriades ES, Eleftheriou A. The impact of migrations on the health services
    for rare diseases in Europe: the example of haemoglobin disorders. ScientificWorldJournal.;2013:727905, 2013
  • Vives-Corrons JL, Briggs C, Simon-Lopez R, Albarede S, de la Salle B, Flegar-Meatrii Z, Nazor A, Guyard A, Lipsic T,
    Nagai Y, Patiu M, Piqueras J, Capel MJ, Van Blerk M, Wang J, Marzac C. Effect of EDTA-anticoagulated whole
    blood storage on cell morphology examination. A need for standardization. Int J Lab Hematol. 36(2):222-6, 2014
  • Vives-Corrons JL, Koralkova P, Grau JM, Mañú Pereira Mdel M, Van Wijk R First description of
    fosphofructokinase deficiency in spain: identification of a novel homozygous missense mutation in the PFKM
    gene. Front Physiol. 30;4:393, 2013
  • Mañú-Pereira Mdel M, Gonzalez-Roca E, van Solinge WW, Llaudet-Planas E, Sevilla J, Montllor L, Mensa-Vilaro
    A, Ploos van Amstel HK, van Wijk R, Vives-Corrons J. Pyruvate kinase deficiency and severe congenital hemolytic
    anemia in a double heterozygous patient with paternal transmission of an early germ-line de novo mutation.
    Am J Hematol. 90(12):E217-9, 2015
  • Garcia-Gomez M, Calabria A, Garcia-Bravo M, Benedicenti F, Kosinski P, López-Manzaneda S, Hill C, Del Mar
    Mañu-Pereira M, Martín MA, Orman I, Vives-Corrons JL, Kung C, Schambach A, Jin S, Bueren JA, Montini E,
    Navarro S, Segovia JC. Safe and Efficient Gene Therapy for Pyruvate Kinase Deficiency. Mol Ther. 24(7):1187-98,
    2016

Ejaz Ahmad Khera | Materials Simulation | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Ejaz Ahmad Khera | Materials Simulation | Best Researcher Award


Dr. Ejaz Ahmad Khera is an Assistant Professor of Physics at The Islamia University of Bahawalpur, Pakistan, and an HEC-approved supervisor with a PhD in the characterization of materials for memory storage and neuromorphic applications using DFT. He has published over 30 high-impact international research articles and currently leads research at the Materials Modeling and Simulation Lab, where he supervises MPhil and PhD students. His group is actively involved in developing efficient double perovskites for solar cell applications. In addition to his academic and research roles, Dr. Khera contributes to departmental administrative functions and has participated in multiple international conferences in physics and materials science. He is proficient in VASP, Wien2k, CASTEP, and other computational tools, reflecting his strong background in computational materials physics.

Profile

Education 🎓

Dr. Khera earned his PhD in Physics from The Islamia University of Bahawalpur (2016–2021), focusing on DFT-based characterization of materials for neuromorphic and memory applications. He holds an MPhil in Physics from Allama Iqbal Open University, Islamabad (2012–2014), and a Master of Science in Physics from Bahauddin Zakariya University, Multan (2007–2010). His academic foundation combines theoretical physics, computational modeling, and practical understanding of solid-state and condensed matter systems. He is trained in multiple simulation platforms including VASP, Wein2k, and CASTEP, and has built expertise in data analysis software like Origin and visualization tools like VESTA and Crystal Maker. His solid academic training has enabled him to mentor graduate students in computational material science and renewable energy research domains. Dr. Khera has also enhanced his academic exposure through participation in pedagogical and research methodology training programs.

Experience 👨‍🏫

Dr. Khera is currently serving as Assistant Professor of Physics at The Islamia University of Bahawalpur since March 2022, where he teaches undergraduate and postgraduate courses, leads research, and manages academic administration. From 2019 to 2021, he was a visiting lecturer at University of Education, Multan Campus, and previously taught physics at Admire Group of Colleges (2017–2021), Muslim Group of Colleges (2013–2017), and Educators Group of Colleges (2011–2013), focusing on undergraduate and higher secondary education. Over a decade of teaching experience has honed his expertise in delivering core physics concepts and mentoring students. In his academic tenure, Dr. Khera has also built research collaborations and guided MPhil and PhD students in materials modeling. His responsibilities have included curriculum design, academic planning, and seminar coordination. He is deeply engaged in academic development through active participation in physics conferences and workshops.

Awards & Recognitions 🏅

Dr. Khera received the Prime Minister Youth Laptop Scheme award from the Federal Government of Pakistan in 2018, recognizing his academic excellence and contribution to higher education. He was also granted the Punjab Government Scholarship under the Fee Reimbursement Scheme for Higher Education in 2017, awarded by the Government of Punjab. These honors reflect his academic merit, commitment to research, and service in the field of physics education. He has participated in multiple international and national-level conferences, including events hosted by The Islamia University of Bahawalpur and The Women University Multan. His consistent performance in academics and his role in teaching and research supervision have earned him institutional recognition. Additionally, his HEC-approved supervisor status further signifies his qualification and leadership in guiding advanced research projects in Pakistan. These accolades support his active involvement in national education development and scientific advancement in materials science.

Research Interests 🔬

Dr. Khera’s research is centered on computational materials science with a focus on density functional theory (DFT)-based investigations of electronic, optical, thermoelectric, and structural properties of novel materials. His primary interest lies in characterizing double perovskites (DPs), Heusler alloys, and vacancy-ordered compounds for use in solar cells, memory storage, brain-inspired neuromorphic systems, and energy harvesting applications. Using simulation tools like VASP, CASTEP, and Wien2k, he studies materials such as Ga₂PtX₆, Li₂ATlCl₆, and Na₂PtX₆ for their optoelectronic and thermoelectric performance. His recent publications explore halogen modification, spin polarization, and hybrid perovskites for sustainable technologies. His research group actively contributes to discovering lead-free, high-efficiency materials that align with global goals for clean and renewable energy. Dr. Khera also collaborates internationally, co-authoring papers with scientists across Asia and Europe, thereby advancing the field of computational physics and sustainable material development.

Publications

 

  • Probing the opto-electronic, thermoelectric, thermodynamic and elastic responses
    of lead-free double perovskite Li2ATlCl6 (A= Na and K) for potential photovoltaic
    and high-energy applications: A DFT study
    Reference: Qiguo Xiao, Abrar Nazir, Ejaz Ahmad Khera, Mumtaz Manzoor, Ramesh
    Sharma, Javed Rahman, Sabah Ansar, Farooq Ali
    Link: https://www.sciencedirect.com/science/article/pii/S0921510724006895

 

  • First principles investigation of structural, electronic, optical, transport properties
    of double perovskites X2TaTbO6 (X= Ca, Sr, Ba) for optoelectronic and energy
    harvesting applications
    Reference: Mudassir Ishfaq, Muniba Urooj, Muhammad Sajid, Khawar Ismail, Rimsha
    Baqeel, Ejaz Ahmad Khera, Rajwali Khan, Sattam Al Otaibi, Khaled Althubeiti, Hassan Ali,
    Ghulam Murtaza, Muhammad Jamil
    Link: https://www.sciencedirect.com/science/article/pii/S0022369724005675

 

 

Nathan Robert Wall | Medicine | Excellence in Research Award

Published on by Cognitive Scientist Awards

Dr. Nathan Robert Wall | Medicine | Excellence in Research Award

Dr. Nathan R. Wall is an accomplished academic, biomedical researcher, and military officer. He is currently an Associate Professor of Medicine at Loma Linda University School of Medicine and holds multiple leadership roles in research, oncology education, and national defense. With advanced degrees in biology, cancer biology, and business administration, he has dedicated his career to cancer research and military medical operations. Dr. Wall has served in multiple deployments with the California Army National Guard, including missions in Afghanistan, Poland, and Iraq. His military and academic excellence is recognized through numerous awards and honors. Dr. Wall combines rigorous research in molecular medicine with a passion for leadership, education, and national service. His extensive experience in academia, clinical research, and military command uniquely positions him at the intersection of science and strategic operations, contributing to both medical advancement and national security.

Profile

Education 🎓

Dr. Nathan R. Wall is currently pursuing a Master of Strategic Studies at the U.S. Army War College (2024–2026). He earned his MBA with a focus in Management from the University of Redlands (2006–2008), and a Ph.D. in Cancer Biology from Wayne State University (1996–2000), where he also completed an M.S. in Molecular Biology and Genetics. Prior to that, he obtained an M.S. in Biology (1992–1995) and a B.S. in Biology with a minor in Chemistry (1987–1991) from Walla Walla College (now Walla Walla University). His graduate training included mentorship under leading scientists like Dr. Ayad M. Al-Katib and Dr. Joan M. Redd. Across disciplines—from molecular biology to strategic leadership—Dr. Wall’s education reflects a commitment to interdisciplinary excellence, equipping him with the skills to navigate both biomedical research and complex military operations with strategic insight.

Experience 👨‍🏫

Dr. Nathan R. Wall has held academic appointments at Loma Linda University since 2008, currently serving as Associate Professor of Medicine in the Division of Human Anatomy. He also directs Research and Development at the James M. Slater Proton Treatment & Research Center and is Oncology Thread Director at the School of Medicine. Previously, he served in the Department of Biochemistry and Center for Health Disparities. Since 2008, Dr. Wall has simultaneously served in the California Army National Guard, rising through the ranks and completing deployments to Afghanistan, Poland, and Iraq in key command roles. He has also contributed as a scientific advisor for biotech firms and participated in Department of Defense medical research review panels. His interdisciplinary experience spans military medicine, molecular oncology, academic leadership, and national defense, making him a unique leader who bridges science, strategy, and service.

Awards & Recognitions 🏅

Dr. Wall’s exemplary service has earned him numerous military and civilian accolades. These include the Bronze Star Medal, NATO Medal, Afghanistan Campaign Medal, Global War on Terrorism Service Medal, and the Honorable Order of Saint Martin. He’s received multiple Army Commendation and Achievement Medals, along with California-specific honors like the California Medal of Merit and Drill Attendance Ribbon with multiple stars. Notably, he was recognized as “Citizen Warrior of the Month” by California ARNG Magazine in August 2018. Dr. Wall has also been honored with plaques and certificates from NATO, Bulgarian Joint Forces, and various military medical programs. His academic achievements include tenure at Loma Linda University and leadership roles in key training inspections. These honors reflect his unwavering commitment to excellence, leadership in medical readiness, and profound impact in both academic and military sectors.

Research Interests 🔬

Dr. Wall’s research focuses on cancer biology, with specific expertise in molecular mechanisms of disease, targeted therapies, and translational oncology. His work bridges basic science and clinical application, especially in the context of proton therapy and health disparities in underserved populations. At Loma Linda University, he leads interdisciplinary teams addressing tumor microenvironments, cancer signaling pathways, and innovative therapeutics. Dr. Wall also contributes to Department of Defense research as a peer reviewer, ensuring scientific rigor in funded medical studies. His research often integrates his military background, exploring how stress and trauma-related factors influence cancer biology and immune responses. As Director of R&D at a leading proton treatment center, he’s advancing precision medicine in oncology. Dr. Wall’s work is marked by its practical implications, scientific depth, and commitment to improving patient care—particularly for populations affected by health inequities or involved in military service.

Publications

  • Seco-Duocarmycin SA in Aggressive Glioblastoma Cell Lines

    International Journal of Molecular Sciences
    2025-03-19 | Journal article
    DOI: 10.3390/ijms26062766
    CONTRIBUTORS: Ann Morcos; Yeonkyu Jung; Ryan N. Fuller; Antonella Bertucci; Amy Nguyen; Quanqing Zhang; Tobias Emge; Kristopher E. Boyle; Nathan R. Wall; Marcelo Vazquez

  • A Comprehensive Review of the Antitumor Properties and Mechanistic Insights of Duocarmycin Analogs

    Cancers
    2024-09-27 | Journal article
    DOI: 10.3390/cancers16193293
    CONTRIBUTORS: Ann Morcos; Yeonkyu Jung; Joab Galvan Bustillos; Ryan N. Fuller; David Caba Molina; Antonella Bertucci; Kristopher E. Boyle; Marcelo E. Vazquez; Nathan R. Wal

  • A CTB-SARS-CoV-2-ACE-2 RBD Mucosal Vaccine Protects Against Coronavirus Infection

    Vaccines
    2023-12-18 | Journal article
    DOI: 10.3390/vaccines11121865
    CONTRIBUTORS: Béla Dénes; Ryan Fuller; Wayne Kelin; Tessa Levin; Jaipuneet Gil; Aaren Harewood; Márta Lőrincz; Nathan Wall; Anthony Firek; William Langridg